Viewing Study NCT05841420


Ignite Creation Date: 2025-12-25 @ 4:14 AM
Ignite Modification Date: 2025-12-28 @ 10:10 AM
Study NCT ID: NCT05841420
Status: RECRUITING
Last Update Posted: 2025-01-29
First Post: 2023-03-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemcitabine Versus Reduced-dose Combination Chemotherapy in Fragile Patients with Non-resectable Pancreatic Cancer
Sponsor: Morten Ladekarl
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module